Cognito Therapeutics - Raised $227M Funding from 6 investors

Oct 29, 2024 · Cognito Therapeutics has raised a total funding of $227M over 5 rounds from 6 investors. Investors include Morningside, FoundersX Ventures and 4 others. Their latest …

CouponFollow Extension

$227
OFF

Cognito Therapeutics - Raised $227M Funding From 6 Investors

6 days from now

Oct 29, 2024 · Cognito Therapeutics has raised a total funding of $227M over 5 rounds from 6 investors. Investors include Morningside, FoundersX Ventures and 4 others. Their latest …

tracxn.com

$227
OFF

Cognito Therapeutics - Company Profile - Tracxn

6 days from now

Oct 29, 2024 · Cognito Therapeutics - Developer of a medical device for the treatment of Alzheimer's disease. Raised a total funding of $227M over 5 rounds from 6 investors. Founded …

tracxn.com

$20
OFF

Cognito Therapeutics Company Profile 2024: Valuation, Funding ...

6 days from now

1. Early Stage VC (Series A) 18-Jul-2016. $20M. $20M. Completed. Pre-Clinical Trials. To view Cognito Therapeutics’s complete valuation and funding history, request access ».

pitchbook.com

$118.25
OFF

Cognito Therapeutics Stock Price, Funding, Valuation, Revenue ...

6 days from now

Jul 2, 2024 · Funding, Valuation & Revenue. Cognito Therapeutics has raised $118.25M over 5 rounds. Cognito Therapeutics's latest funding round was a Series B - III for $10.25M on July 2, …

cbinsights.com

$73
OFF

Series B - Cognito Therapeutics - 2023-03-22 - Crunchbase

6 days from now

Mar 22, 2023 · Built In Boston — Cognito Raises $73M to Combat Alzheimer’s Disease. News • Mar 22, 2023. Business Wire — Cognito Therapeutics Raises $73M Series B to Advance …

crunchbase.com

$73
OFF

Firm Advises Cognito Therapeutics On $73 Million Series B Financing

6 days from now

Mar 31, 2023 · On March 22, 2023, neurotechnology company Cognito Therapeutics announced a $73 million Series B financing round. The financing was led by FoundersX Ventures with …

wsgr.com

$35
OFF

Cognito Nets $35 Million To Advance Alzheimer's DTx Trial

6 days from now

Jan 29, 2024 · Cognito Therapeutics has raised $35 million to advance its digital therapeutic (DTx) for Alzheimer's disease, the company's CEO Brent Vaughan told FirstWord HealthTech …

firstwordhealthtech.com

$35
OFF

Cognito Secures Funding To Test Medical Device For Alzheimer's

6 days from now

Jan 29, 2024 · Adobe. J ust as a new wave of approved drugs for Alzheimer’s disease reaches patients, medical device company Cognito Therapeutics has raised a fresh $35 million to …

statnews.com

$73
OFF

Cognito Collects $73M For Light-and-sound Alzheimer's Therapy

6 days from now

Mar 22, 2023 · The series B round adds $73 million to Cognito’s coffers, the startup announced Wednesday. It’ll go toward the ongoing pivotal study of the noninvasive headset, which relies …

fiercebiotech.com

$73
OFF

Cognito Therapeutics Raises $73M Series B To Advance …

6 days from now

Mar 22, 2023 · The funding will advance Cognito’s pivotal study of its non-invasive neuromodulation device, which delivers proprietary gamma frequency light and sound …

businesswire.com

$35
OFF

Cognito Therapeutics Raises $35M Series B Extension - VatorNews

6 days from now

The round is an extension of the Series B round the company raised $73 million in March 2023 from FoundersX, Morningside, Alzheimer’s Drug Discovery Foundation, IAG Capital, …

vator.tv

$108765300
OFF

Venture Round - Cognito Therapeutics - 2022-06-27 - Crunchbase

6 days from now

Jun 27, 2022 · Cognito Therapeutics raised $108765300 on 2022-06-27 in Venture Round. Search Crunchbase. Start Free Trial . ... Save . Summary. Overview. Edit Overview Section. …

crunchbase.com

$73
OFF

Cognito Therapeutics Scores $73m Series B - Venture Capital Journal

6 days from now

Mar 22, 2023 · The funding will advance Cognito’s study of its non-invasive neuromodulation device. Cambridge, Massachusetts-based Cognito Therapeutics, a neurotechnology company …

venturecapitaljournal.com

$35000000
OFF

Series B - Cognito Therapeutics - 2024-01-29 - Crunchbase

6 days from now

Jan 29, 2024 · Cognito Therapeutics raised $35000000 on 2024-01-29 in Series B. ... Summary. Overview. Edit Overview Section. Organization Name . Cognito Therapeutics . Announced …

crunchbase.com

$73
OFF

Cognito's Experimental Headset To Treat Alzheimer's Disease

6 days from now

Mar 22, 2023 · Cognito Therapeutics raised $73 million to test this theory in hundreds of people. For decades, biotech companies have struggled to develop treatments for Alzheimer's …

businessinsider.com

FAQs about Cognito Therapeutics - Raised $227M Funding from 6 investors Coupon?

How much money has Cognito Therapeutics raised?

Cognito Therapeutics has raised a total of $126.3M in funding over 2 rounds. Their latest funding was raised on Mar 22, 2023 from a Series B round. Cognito Therapeutics is funded by 5 investors. IAG Capital Partners and FoundersX Ventures are the most recent investors. Cognito Therapeutics has raised a total of $126.3M in funding over 2 rounds. ...

Who invested in Cognito Therapeutics?

Cognito Therapeutics has 7 investors. Alzheimer's Drug Discovery Foundation invested in Cognito Therapeutics's Series B funding round. Greffex is the developer of the GREVAX Universal Platform, which delivers vaccines in a fast, efficient and affordable manner, including nationwide production-to-delivery within weeks. ...

Does Cognito therapeutics have a series B financing?

CAMBRIDGE, Mass.-- ( BUSINESS WIRE )-- Cognito Therapeutics, a neurotechnology company advancing disease-modifying therapies to treat CNS diseases, announced today a $73M Series B financing round led by FoundersX Ventures with participation from all existing investors. ...

Who is Cognito Therapeutics?

Cognito Therapeutics is a neurotechnology company that is developing disease-modifying treatments for CNS illnesses. Cognito Therapeutics is a neurotechnology company that is developing disease-modifying treatments for CNS illnesses. ...

Where is Cognito based?

The Company’s lead therapy is currently in a pivotal study in Alzheimer’s Disease and was awarded FDA Breakthrough Device Designation. Cognito is based in Cambridge, MA. For more information, visit www.cognitotx.com. Follow us on Twitter at @cognitotx. ...

Who will join Cognito's Board of directors?

In addition to the financing, Dr. Rick Kuntz, MD, MSc, former Senior Vice President, Chief Medical and Scientific Officer of Medtronic and Helen Liang, Founder & Managing Partner at FoundersX, will join Cognito’s Board of Directors. Dr. ...